Treating the leading killer

Science Translational Medicine

Volumn 4, Issue 146, 2012, Pages

  Christman, Karen L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 INTEGRIN; BIOMATERIAL; MOLECULAR SCAFFOLD; VASCULOTROPIN;

ANGIOGENESIS; ANOIKIS; ANTIANGIOGENIC ACTIVITY; CELL INFILTRATION; CELL TRANSPLANTATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG MEGADOSE; EXTRACELLULAR MATRIX; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; MICROENVIRONMENT; MINIMALLY INVASIVE PROCEDURE; MONONUCLEAR CELL; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCAR FORMATION; SHORT SURVEY; TISSUE ENGINEERING; TRANSDERMAL PATCH;

ANIMALS; MALE; NANOFIBERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864875094     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004565     Document Type: Short Survey

References (10)

1. V. L. Roger, A. S. Go, D. M. Lloyd-Jones, E. J. Benjamin, J. D. Berry, W. B. Borden, D. M. Bravata, S. Dai, E. S. Ford, C. S. Fox, H. J. Fullerton, C. Gillespie, S. M. Hailpern, J. A. Heit, V. J. Howard, B. M. Kissela, S. J. Kittner, D. T. Lackland, J. H. Lichtman, L. D. Lisabeth, D. M. Makuc, G. M. Marcus, A. Marelli, D. B. Matchar, C. S. Moy, D. Mozaff arian, M. E. Mussolino, G. Nichol, N. P. Paynter, E. Z. Soliman, P. D. Sorlie, N. Sotoodehnia, T. N. Turan, S. S. Virani, N. D. Wong, D. Woo, M. B. Turner, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 125, e2-e220 (2012).
2. Y.-D. Lin, C.-Y. Luo, Y.-N. Hu, M.-L. Yeh, Y.-C. Hsueh, M.-Y. Chang, D.-C. Tsai, J.-N. Wang, M.-J. Tang, E. I. H. Wei, M. L. Springer, P. C. H. Hsieh, Instructive nanofi ber scaff olds with VEGF create a microenvironment for arteriogenesis and cardiac repair. Sci. Transl. Med. 4, 146ra109 (2012).
3. D. L. Mann, Mechanisms and models in heart failure: A combinatorial approach. Circulation 100, 999-1008 (1999).
4. A. A. Rane, K. L. Christman, Biomaterials for the treatment of myocardial infarction: A 5-year update. J. Am. Coll. Cardiol. 58, 2615-2629 (2011).
5. Y. D. Lin, M. L. Yeh, Y. J. Yang, D. C. Tsai, T. Y. Chu, Y. Y. Shih, M. Y. Chang, Y. W. Liu, A. C. Tang, T. Y. Chen, C. Y. Luo, K. C. Chang, J. H. Chen, H. L. Wu, T. K. Hung, P. C. Hsieh, Intramyocardial peptide nanofi ber injection improves postinfarction ventricular remodeling and effi cacy of bone marrow cell therapy in pigs. Circulation 122, (suppl.), S132-S141 (2010).
6. P. C. Hsieh, C. MacGillivray, J. Gannon, F. U. Cruz, R. T. Lee, Local controlled intramyocardial delivery of plateletderived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation 114, 637-644 (2006).
7. J. Leor, S. Tuvia, V. Guetta, F. Manczur, D. Castel, U. Willenz, O. Petneházy, N. Landa, M. S. Feinberg, E. Konen, O. Goitein, O. Tsur-Gang, M. Shaul, L. Klapper, S. Cohen, Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J. Am. Coll. Cardiol. 54, 1014-1023 (2009).
8. M. E. Davis, J. P. Motion, D. A. Narmoneva, T. Takahashi, D. Hakuno, R. D. Kamm, S. Zhang, R. T. Lee, Injectable selfassembling peptide nanofi bers create intramyocardial microenvironments for endothelial cells. Circulation 111, 442-450 (2005).
9. J. M. Singelyn, P. Sundaramurthy, T. D. Johnson, P. J. Schup-Magoffi n, D. P. Hu, D. M. Faulk, J. Wang, K. M. Mayle, K. Bartels, M. Salvatore, A. M. Kinsey, A. N. Demaria, N. Dib, K. L. Christman, Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J. Am. Coll. Cardiol. 59, 751-763 (2012).
10. H. Hamamoto, J. H. Gorman III, L. P. Ryan, R. Hinmon, T. P. Martens, M. D. Schuster, T. Plappert, M. Kiupel, M. G. St. John-Sutton, S. Itescu, R. C. Gorman, Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: The eff ect of cell dosage. Ann. Thorac. Surg. 87, 794-801 (2009).